Vemlidy

(Tenofovir Alafenamide Citrate)

Phase 2Small molecule

Gilead

Vemlidy is one of 44 small molecule programs targeting Liver Transplant. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

FDA Application

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[3][1]

Indication

Liver TransplantNot yet recruiting

Liver TransplantPhase 2

Not yet recruiting

Competition

Competitive Landscape

96 competitors in Liver Transplant

#DrugCompanyPhaseTrials

Giapreza

LLa Jolla Pharmaceutical Company

Phase 3

1 2

Darbepoetin

Bayer

Phase 3

1 3

Prothrombin Complex Concentrate

CSL Behring

Phase 3

1 4

Rezzayo

MMundipharma (China) Pharmaceutical Co. Ltd

Phase 3

1 5

Lenvima

Eisai

Preclinical

2 6

Octreotide

Johnson & Johnson

Preclinical

2 7

Beyfortus

BeiGene

Preclinical

1 8

Prostigmin

Merck & Co.

Preclinical

1 9

Myfortic

Novartis

Preclinical

1 10

Vemlidy

Gilead

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Liver Transplant1 trial

To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients

Not yet recruiting·UUnknown Sponsor·Phase 2·NCT06589518·108 enrolled

Regulatory

FDA Approval Timeline[4]

Nov 10, 2016

VEMLIDY

NDA NDA208464

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Tenofovir Alafenamide Citrate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tenofovir Alafenamide Citrate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tenofovir Alafenamide Citrate. EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA208464). U.S. Food & Drug Administration.
[5]
SEC EDGAR — Gilead company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: Gilead

Vemlidy

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Liver Transplant1 trial

FDA Approval Timeline[4]

References

Drug Info

Quick Facts

Related News